Creative Medical Technology Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2018-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, new issues for fiscal 2024 was $100.00.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, new issues for fiscal 2017 was $100.00K, a 78.72% decline from fiscal 2016.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, new issues for fiscal 2016 was $470.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $100.00 10-K · filed 2026-03-20 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-20 | |
| 2017-12-31 | $100.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $470.00K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |